Kira Gordon


Kira Gordon is a Principal in the Life Sciences Practice at CRA specializing in strategy consulting. She has consulted on projects across number of therapeutic areas and healthcare markets.

Her project work focuses primarily on pricing & market access strategy and opportunity assessment/diligence support. Ms. Gordon has experience with both drugs and devices across a broad range of therapy areas, with a particular emphasis on medical-surgical devices, hospital drugs, metabolic syndrome, and outpatient specialty therapeutics in categories including oncology, neurology-psychology, autoimmune, and rare disease.

Selected engagements

  • 01
    Modeling the financial implications of innovative gene therapy business models
    Biotech client was looking to evaluate the financial implications of various innovative business models/strategic offerings for its novel gene therapy.
    View engagement
  • 02
    Understanding medical device regulations, P&R, and access landscape
    Our client approached us to map a medical device regulatory pathway used as part of inpatient and ambulatory procedures.
    View engagement